- Home
- AIRS vs ANIK Comparison
AIRS vs ANIK Comparison
Compare AIRS & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRS | ANIK |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 192.4M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AIRS | ANIK |
|---|---|---|
| Price | $2.18 | $14.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 614.7K | 128.3K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,350,000.00 | $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $2.55 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.51 | $7.90 |
| 52 Week High | $12.00 | $16.70 |
Technical Indicators
Market Signals| Indicator | AIRS | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 72.76 |
| Support Level | $1.85 | $9.43 |
| Resistance Level | $3.29 | N/A |
| Average True Range (ATR) | 0.22 | 0.74 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 81.78 | 83.26 |
Price Performance
Historical ComparisonAbout AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.